Dae-Hyun Kim1, Jeffrey L Saver2, Sidney Starkman1, David S Liebeskind1, Latisha K Ali1, Lucas Restrepo1, May Kim-Tenser1, Miguel Valdes-Sueiras1, Marc Eckstein1, Frank Pratt1, Samuel Stratton1, Scott Hamilton1, Robin Conwit1, Nerses Sanossian1. 1. From the Department of Neurology, Busan-Ulsan Regional Cardiocerebrovascular Center, College of Medicine, Dong-A University, Busan, Republic of Korea (D.-H.K.); Departments of Neurology (J.L.S., D.S.L., L.K.A., L.R., M.V.-S.), Emergency Medicine and Neurology (S.S.), Comprehensive Stroke Center, and Department of Emergency Medicine, Los Angeles County Fire EMS Agency (F.P.), David Geffen School of Medicine, University of California, Los Angeles; Department of Neurology, Roxanna Todd Hodges Comprehensive Stroke Clinic (M.K.-T., N.S.) and Department of Emergency Medicine, Los Angeles Fire Department (M.E.), Keck School of Medicine, University of Southern California, Los Angeles; Department of Emergency Medicine, Los Angeles EMS Agency, Orange County EMS Agency, Harbor-University of California, Los Angeles Medical Center (S.S.); Stanford University, Palo Alto, CA (S.H.); and National Institute of Neurological Disorders and Stroke, Bethesda, MD (R.C.). 2. From the Department of Neurology, Busan-Ulsan Regional Cardiocerebrovascular Center, College of Medicine, Dong-A University, Busan, Republic of Korea (D.-H.K.); Departments of Neurology (J.L.S., D.S.L., L.K.A., L.R., M.V.-S.), Emergency Medicine and Neurology (S.S.), Comprehensive Stroke Center, and Department of Emergency Medicine, Los Angeles County Fire EMS Agency (F.P.), David Geffen School of Medicine, University of California, Los Angeles; Department of Neurology, Roxanna Todd Hodges Comprehensive Stroke Clinic (M.K.-T., N.S.) and Department of Emergency Medicine, Los Angeles Fire Department (M.E.), Keck School of Medicine, University of Southern California, Los Angeles; Department of Emergency Medicine, Los Angeles EMS Agency, Orange County EMS Agency, Harbor-University of California, Los Angeles Medical Center (S.S.); Stanford University, Palo Alto, CA (S.H.); and National Institute of Neurological Disorders and Stroke, Bethesda, MD (R.C.). jsaver@mednet.ucla.edu.
Abstract
BACKGROUND AND PURPOSE: The enrollment yield and reasons for screen failure in prehospital stroke trials have not been well delineated. METHODS: The Field Administration of Stroke Therapy-Magnesium (FAST-MAG) trial identified patients for enrollment using a 2 stage screening process-paramedics in person followed by physician-investigators by cell phone. Outcomes of consecutive screening calls from paramedics to enrolling physician-investigators were prospectively recorded. RESULTS: From 2005 to 2012, 4458 phone calls were made by paramedics to physician-investigators, an average of 1 call per vehicle every 135.7 days. A total of 1700 (38.1%) calls resulted in enrollments. The rate of enrollment of stroke mimics was 3.9%. Among the 2758 patients not enrolled, 3140 reasons for screen failure were documented. The most common reasons for nonenrollment were >2 hours from last known well (17.2%), having a prestroke condition causing disability (16.1%), and absence of a consent provider (9.5%). Novel barriers for phone informed consent specific to the prehospital setting were infrequent, but included: cell phone connection difficulties (3.2%), patient being hard of hearing (1.4%), insufficient time to complete consent (1.3%), or severely dysarthric (1.3%). CONCLUSIONS: In this large, multicenter prehospital trial, nearly 40% of every calls from the field to physician-investigators resulted in trial enrollments. The most common reasons for nonenrollment were out of window last known well time, prestroke confounding medical condition, and absence of a consent provider. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00059332.
RCT Entities:
BACKGROUND AND PURPOSE: The enrollment yield and reasons for screen failure in prehospital stroke trials have not been well delineated. METHODS: The Field Administration of Stroke Therapy-Magnesium (FAST-MAG) trial identified patients for enrollment using a 2 stage screening process-paramedics in person followed by physician-investigators by cell phone. Outcomes of consecutive screening calls from paramedics to enrolling physician-investigators were prospectively recorded. RESULTS: From 2005 to 2012, 4458 phone calls were made by paramedics to physician-investigators, an average of 1 call per vehicle every 135.7 days. A total of 1700 (38.1%) calls resulted in enrollments. The rate of enrollment of stroke mimics was 3.9%. Among the 2758 patients not enrolled, 3140 reasons for screen failure were documented. The most common reasons for nonenrollment were >2 hours from last known well (17.2%), having a prestroke condition causing disability (16.1%), and absence of a consent provider (9.5%). Novel barriers for phone informed consent specific to the prehospital setting were infrequent, but included: cell phone connection difficulties (3.2%), patient being hard of hearing (1.4%), insufficient time to complete consent (1.3%), or severely dysarthric (1.3%). CONCLUSIONS: In this large, multicenter prehospital trial, nearly 40% of every calls from the field to physician-investigators resulted in trial enrollments. The most common reasons for nonenrollment were out of window last known well time, prestroke confounding medical condition, and absence of a consent provider. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00059332.
Authors: Kristina Dupont Hougaard; Niels Hjort; Dora Zeidler; Leif Sørensen; Anne Nørgaard; Troels Martin Hansen; Paul von Weitzel-Mudersbach; Claus Z Simonsen; Dorte Damgaard; Hanne Gottrup; Kristina Svendsen; Peter Vestergaard Rasmussen; Lars R Ribe; Irene K Mikkelsen; Kartheban Nagenthiraja; Tae-Hee Cho; Andrew N Redington; Hans Erik Bøtker; Leif Østergaard; Kim Mouridsen; Grethe Andersen Journal: Stroke Date: 2013-11-07 Impact factor: 7.914
Authors: Jeffrey L Saver; Sidney Starkman; Marc Eckstein; Samuel Stratton; Frank Pratt; Scott Hamilton; Robin Conwit; David S Liebeskind; Gene Sung; Nerses Sanossian Journal: Int J Stroke Date: 2014-02 Impact factor: 5.266
Authors: Jeffrey L Saver; Sidney Starkman; Marc Eckstein; Samuel Stratton; Frank Pratt; Scott Hamilton; Robin Conwit; David S Liebeskind; Gene Sung; Nerses Sanossian Journal: Int J Stroke Date: 2014-01-13 Impact factor: 5.266
Authors: Sandeep Ankolekar; Michael Fuller; Ian Cross; Cheryl Renton; Patrick Cox; Nikola Sprigg; A Niroshan Siriwardena; Philip M Bath Journal: Stroke Date: 2013-09-03 Impact factor: 7.914
Authors: Jeffrey L Saver; Sidney Starkman; Marc Eckstein; Samuel J Stratton; Franklin D Pratt; Scott Hamilton; Robin Conwit; David S Liebeskind; Gene Sung; Ian Kramer; Gary Moreau; Robert Goldweber; Nerses Sanossian Journal: N Engl J Med Date: 2015-02-05 Impact factor: 91.245
Authors: Joseph P Broderick; Yuko Y Palesch; Andrew M Demchuk; Sharon D Yeatts; Pooja Khatri; Michael D Hill; Edward C Jauch; Tudor G Jovin; Bernard Yan; Frank L Silver; Rüdiger von Kummer; Carlos A Molina; Bart M Demaerschalk; Ronald Budzik; Wayne M Clark; Osama O Zaidat; Tim W Malisch; Mayank Goyal; Wouter J Schonewille; Mikael Mazighi; Stefan T Engelter; Craig Anderson; Judith Spilker; Janice Carrozzella; Karla J Ryckborst; L Scott Janis; Renée H Martin; Lydia D Foster; Thomas A Tomsick Journal: N Engl J Med Date: 2013-02-07 Impact factor: 91.245
Authors: Angel Chamorro; Sergio Amaro; Mar Castellanos; Tomás Segura; Juan Arenillas; Joan Martí-Fábregas; Jaime Gállego; Jurek Krupinski; Meritxell Gomis; David Cánovas; Xavier Carné; Ramón Deulofeu; Luis San Román; Laura Oleaga; Ferran Torres; Anna M Planas Journal: Lancet Neurol Date: 2014-04-02 Impact factor: 44.182
Authors: Lisa Shaw; Christopher Price; Sally McLure; Denise Howel; Elaine McColl; Paul Younger; Gary A Ford Journal: Emerg Med J Date: 2013-09-27 Impact factor: 2.740
Authors: Amanda L Porter; James Ebot; Karen Lane; Lesia H Mooney; Amy M Lannen; Eugene M Richie; Rachel Dlugash; Steve Mayo; Thomas G Brott; Wendy Ziai; William D Freeman; Daniel F Hanley Journal: Neurocrit Care Date: 2020-02 Impact factor: 3.210